Prognosis when Using Extracorporeal Membrane Oxygenation (ECMO) for Critically Ill COVID-19 Patients in China: a Retrospective Case Series

Anticoagulant Monitoring Techniques in a Heparin-Induced Thrombocytopenia Patient Undergoing Cardiopulmonary Bypass Using Bivalirudin Anticoagulant

Heparin is widely used as the anticoagulant of choice for cardiopulmonary bypass. However, some patients exposed to heparin therapies develop heparin-induced thrombocytopenia (HIT).

Evaluation of Biocompatible Cardiopulmonary Bypass Circuit Use During Pediatric Open Heart Surgery

The contact of blood with nonbiological surfaces during cardiopulmonary bypass (CPB) induces a whole body inflammatory response and increases postoperative morbidity directly related to bleeding complications and end organ dysfunction.